coli (EHEC) adhesion and reduce biofilm formation [96, 97]
BPC-157 was administered at doses of 10 g/kg, 1 g/kg, 100 ng/kg, and 10 ng/kg throughout the experiment, starting on day zero when therapy began, and daily during the trial periods of 7, 14, 21, 28, and 42 days
Additionally, there is an increase in circulating chemoattractant molecules, like monocyte chemoattractant protein (MCP)-1 and IL-8 (Close et al., 2013)
Biochemia Medica 25(2):141151 Guo X, Yu Y, Liu X, Zhang Y, Guan T, Xie G, Wei J (2014) Heterologous expression and characterization of human cellular glutathione peroxidase mutants
The choice of non-GMO sunflower-derived phosphatidylcholine over cheaper soy alternatives